News
More than 50 corneal blind Papua New Guineans regain their sight from the Cornea Transplant program in Papua New Guinea by ...
18h
Zacks Investment Research on MSNKRYS Up 4% on Initiating Dosing in Rare Eye Disease Phase III StudyShares of Krystal Biotech KRYS gained 4.2% on Tuesday after the company announced that it has dosed the first patient in the ...
14h
CNET on MSN10 Tips to Keep Your Eyes Healthy As You AgeYou might be used to slathering on sunscreen to protect your skin, but have you been protecting your eyes as well? We only ...
Five years after a Fourth of July fireworks accident blinded him, a young man has regained his eyesight thanks to a ...
Nanomaterials are improving ophthalmic care by enhancing drug delivery, diagnostic imaging, and tissue regeneration. This ...
One of the early warning signs of high cholesterol can often be detected during a routine eye exam. Your optician may notice ...
2d
CNET on MSNAre You Replacing Your Contact Lenses Often Enough? Here's What Happens When They ExpireWhile most contact lenses will last for the intended duration, some factors may shorten their lifespan. For instance, dust ...
Perimenopause, or menopausal transition, marks the gradual shift in a woman’s reproductive life when hormone levels, ...
A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms ...
Before you start obsessing over the color of your lenses, put the safety of your eyes first. When picking sunglasses insist ...
22h
GlobalData on MSNStuart reports initial outcomes from trial of ophthalmic solution for DEDStuart Therapeutics has reported initial findings from its 29-day randomised Phase III trial of the ST-100 (vezocolmitide) ophthalmic solution for treating dry eye disease (DED). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results